LIPELLA PHARMACEUTICALS INC. — Form D/A

LIPELLA PHARMACEUTICALS INC. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2021-05-17. The offering totals $3.6M, of which $3.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
David BattlemanDirectorNew York, NY
THOMAS PETZINGER, JR.DirectorPITTSBURGH, PA
Daniel CohenDirectorTel Aviv, L3
Lori BirderDirectorPittsburgh, PA
Michael ChancellorDirectorPittsburgh, PA
Michael ChancellorExecutive OfficerPittsburgh, PA
Michael ChancellorPromoterPittsburgh, PA
Ryan PruchnicDirectorPittsburgh, PA
Jonathan KaufmanDirectorPittsburgh, PA
Jonathan KaufmanExecutive OfficerPittsburgh, PA
Jonathan KaufmanPromoterPittsburgh, PA
Byong KimDirectorPittsburgh, PA
Douglas JohnstonExecutive OfficerPittsburgh, PA
Naoki YoshimuraDirectorPittsburgh, PA
Leaf HuangDirectorChapel Hill, NC
Leaf HuangPromoterChapel Hill, NC
PRADEEP TYAGIPromoterPITTSBURGH, PA
BERNARD TOKARCZYKExecutive OfficerPITTSBURGH, PA

Other filings by this issuer (10)

FiledFormOfferingSold
2025-04-01D$9K$9K
2025-01-07D$6.0M$2.6M
2024-08-15D$120K$120K
2023-11-07D$2.0M$2.0M
2023-09-12D$122K
2021-04-12D/A$3.0M$2.6M
2020-11-04D$3.0M$405K
2011-01-27D/A$1.0M$251K
2010-01-29D/A$1.0M$216K
2009-09-29D/A$1.0M$146K

More